Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegaferon in Hepatitis C
NCT01137383Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2007
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated interferon alpha in hepatitis C (HCV), sponsored by Tehran University of Medical Sciences. Started Dec 2007; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01137383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01137383.